Norepinephrine Noridem (Noradrenaline Tartrate)

Noradrenaline Tartrate, the active ingredient in Norepinephrine Noridem, is a sympathomimetic (alpha‑adrenergic agonist) presented as an injectable solution for intravenous use. Classified as a vasopressor/antihypotensive, it is employed to rapidly increase systemic vascular resistance and cardiac output, thereby raising blood pressure in acute hypotensive states such as septic or cardiogenic shock and during cardiac arrest.

GNH USA supplies Norepinephrine Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Norepinephrine Noridem acts on the sympathetic vascular system to counteract severe hypotension.

- Acute hypotension: restores vascular tone and raises systemic blood pressure. - Septic shock: improves perfusion pressure and supports organ function. - Cardiogenic shock: enhances cardiac output while maintaining coronary perfusion. - Cardiac arrest: provides essential vasoconstriction as part of advanced life support protocols.

Norepinephrine may be associated with a range of adverse reactions, varying from common to serious.

Common Side Effects: - Headache - Tachycardia - Peripheral ischemia or cold extremities - Anxiety or restlessness - Nausea or vomiting

Serious or Rare Side Effects: - Severe hypertension - Myocardial ischemia or infarction - Cardiac arrhythmias - Tissue necrosis at extravasation sites - Pulmonary edema

When using Norepinephrine Noridem, careful monitoring and specific precautions are essential to ensure safety.

- Monitor blood pressure continuously: adjust infusion rate to maintain target MAP. - Use central venous access when possible: reduces risk of extravasation. - Assess cardiac function regularly: watch for tachyarrhythmias or ischemia. - Avoid rapid bolus administration: infuse gradually to prevent sudden hypertension. - Limit use in patients with uncontrolled hypertension: may exacerbate condition. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine can interact with several medications, influencing its efficacy or safety profile.

Major Interactions (Avoid): - MAO inhibitors: may cause excessive hypertension. - Other vasopressors (e.g., phenylephrine): additive pressor effects leading to severe hypertension. - Beta‑blockers: can blunt beta‑1 mediated cardiac effects, altering response.

Moderate Interactions (Monitor Closely): - Tricyclic antidepressants: increase risk of hypertension. - Vasodilators (e.g., nitroglycerin): may reduce pressor effectiveness. - Anesthetics (e.g., halothane): can potentiate cardiovascular instability.